Two More Investors Sue Theranos and Elizabeth Holmes for Fraud This is the first lawsuit against Theranos that's seeking class-action status.

By Mariella Moon

This story originally appeared on Engadget

via Engadget

Two more investors have filed lawsuits against Theranos, a few weeks after Walgreens sued the embattled startup for $140 million. This is the third one filed against the company, following the drugstore chain's and Partner Fund Management's (PFM), but the first that's seeking class-action status. The plaintiffs echo PFM's lawsuit from October, accusing Theranos founder Elizabeth Holmes and former president Ramesh "Sunny" Balwani of spoon-feeding investors continuous lies, making false promises "built on false statements and omissions." They said the company's head honchos told the public they perfected a "revolutionary technology" vetted by experts and regulators that will change the world of lab testing, knowing full well that it'll reach investors' ears.

As you know by now, things went awry after a series of Wall Street Journal reports came out in 2015, revealing that Theranos was conducting most of its tests using typical lab practices and equipment instead of its proprietary machine. If you'll recall, the company said its machine can produce test results from a single drop of blood -- a service people could avail through Walgreens' outlets. Because ordinary lab equipment requires more blood than that, the accuracy of Theranos' blood test results were called into question. Since then, Walgreens severed its ties with the company, Holmes was banned from running a lab for a couple of years and Theranos had to let most of its employees go.

One of the two plaintiffs in this lawsuit is well-known Silicon Valley investment banker Robert Colman. He invested in the company when it announced its partnership with Walgreens back in 2013. The second plaintiff, Hilary Taubman-Dye, was a victim of bad timing. She bought shares through online exchange platform SharesPost Inc. in August 2015, a couple of months before WSJ's exposé was published. According to the publication, she tried to cancel the transaction after the scandal broke. Unfortunately, that didn't work out, and her transaction went through in December.

The Hagens Berman Sobol Shapiro law firm is going all out with this case. It's currently looking for more investors to join the class-action lawsuit and even whistleblowers who can provide information to help with its investigation.

Mariella Moon is an associate editor at Engadget.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Side Hustle

This 30-Year-Old's $6,000-a-Month Side Hustle Started Making Money 'Immediately' — But He's Not Quitting His Day Job

Derrick Mathy works in orthopedic surgical device sales and is on a mission to bring people together in real life.

Thought Leaders

Cultural Fit Can Make or Break an M&A Deal

One of the most critical components for success -- cultural fit -- often falls by the wayside.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Business News

'Unprecedented in Our 53-Year History': Southwest Airlines Announces Its First Mass Layoffs Ever

The airline is eliminating 15% of its corporate workforce, including many in senior leadership positions.

Side Hustle

'I Was Called Crazy': This 27-Year-Old's Side Hustle Hit $30,000 a Month in Under a Year — Now It's Worth Millions

Changing regulations forced Angel Rodriguez's jet ski rental company to shut down, and the young entrepreneur had to figure out his next move — fast.

Business News

Elon Musk's xAI Claims Its New Grok 3 AI Is Better Than ChatGPT and DeepSeek: 'Seeing the Beginnings of Creativity'

xAI debuted the new AI on Monday, claiming it has 10 times the computational power of Grok 2.